StockWatch
·
Biotechnology: Commercial Physical & Biological Resarch
LegalAug 11, 2026, 05:27 PM

iSpecimen Settles Arbitration with WestPark Capital for $97,500

AI Summary

iSpecimen Inc. entered into a Settlement Agreement and Mutual Release with WestPark Capital, Inc., resolving an arbitration where WestPark had sought nearly $270,000 in damages. Under the agreement, iSpecimen paid WestPark $97,500, and the arbitration was dismissed with prejudice. The settlement also terminates the Engagement Agreements for investment banking services, including those related to a public offering that raised approximately $4.0 million, and includes a mutual general release of claims.

Key Highlights

  • iSpecimen Inc. settled an arbitration with WestPark Capital, Inc. for $97,500.
  • WestPark Capital had sought damages of $269,999.91 in the arbitration.
  • The arbitration was dismissed with prejudice on August 10, 2026.
  • Engagement Agreements with WestPark Capital were terminated in their entirety.
  • WestPark Capital acted as underwriter for a public offering that closed on July 25, 2025.
  • The public offering raised approximately $4.0 million in gross proceeds.
  • The $97,500 settlement payment will be recorded as a charge in the quarter ending September 30, 2026.
  • No early termination penalties were incurred.